Answers are grounded in this paper and cite their sources.
Combined treatment with a polypill plus aspirin led to a lower incidence of cardiovascular events than did placebo among participants without cardiovascular disease who were at intermediate cardiovascular risk. (Funded by the Wellcome Trust and others; TIPS-3 ClinicalTrials.gov number, NCT01646437.).
No takes yet. Share an insight, caveat, or question.
Yusuf et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: